S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.17 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.17 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.17 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.17 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Forecast, Price & News

$0.05
0.00 (0.00%)
(As of 05/31/2023 ET)
Compare
Today's Range
$0.05
▼
$0.05
50-Day Range
$0.00
▼
$0.05
52-Week Range
$0.00
▼
$0.54
Volume
3,189 shs
Average Volume
418 shs
Market Capitalization
$3.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest

ACUR stock logo

About Acura Pharmaceuticals (OTCMKTS:ACUR) Stock

Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.

Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACUR Stock News Headlines

May 31, 2023 | msn.com
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer
May 3, 2023 | marketwatch.com
Exploring the Growth Potential of the Opioid Drugs Market till 2031
June 1, 2023 | Edge On The Street (Ad)
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
April 27, 2023 | marketwatch.com
Azilsartan Medoxomil API Market Forecast to 2030
April 22, 2023 | thestreet.com
4 Stocks Under $10 Moving Higher
April 9, 2023 | benzinga.com
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of Transactions
April 9, 2023 | marketwatch.com
Opioid Drugs Market Sales By 2030
March 29, 2023 | marketwatch.com
Calming and Sleeping Market Outlook and Forecast till 2028
June 1, 2023 | Edge On The Street (Ad)
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
March 13, 2023 | thestreet.com
Acura Stock Soars (ACUR)
February 17, 2023 | marketwatch.com
Opioid Drugs Market Forcast 2023 To 2028 : In-depth Research Analysis with Top Countries Data
February 13, 2023 | marketwatch.com
Azilsartan Medoxomil API Market 2023-2029 Global Forecast with Top Key Players such as: Takeda, Lupin, Acura Labs, Metrochem API
February 8, 2023 | marketwatch.com
Opioid Drugs Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2028
January 25, 2023 | marketwatch.com
Analysis of Azilsartan Medoxomil API Market for the Period 2023 to 2028 : Development, Growth and Key Factors
January 5, 2023 | thestreet.com
Pfizer, Acura Painkiller Approved by FDA
September 4, 2022 | msn.com
Woman shot in face, hand in drive-by shooting on Queens street, 2 vehicles sought
August 18, 2022 | marketwatch.com
Calming and Sleeping Market Size and Growth 2022 Analysis Report by Manufactures, Trends, Share, Opportunity, Regions and Forecast to 2028
July 10, 2022 | morningstar.com
Acura Pharmaceuticals Inc - Stock Quote ACUR
July 4, 2022 | nypost.com
Don’t blame gas station owners over sky-high prices, drivers tell Biden
July 1, 2022 | thestreet.com
American Realty Investors Inc. News
July 1, 2022 | marketwatch.com
Opioid Drugs Market Newly Updated 85 Page Reports Provide an In-Depth Analysis of the Covid-19 Till 2028
June 6, 2022 | msn.com
Opening Bell: Bear market rally incoming
May 19, 2022 | marketwatch.com
Calming and Sleeping Market Size 2022 Research Findings, Market Growth Factors Analysis and Forecasts – 2026
March 1, 2022 | seekingalpha.com
Acura, Abuse Deterrent Pharmaceuticals amend license deal for pain drug LIMITx LTX-03
January 21, 2022 | yahoo.com
The Latino Filmmakers Network and Homestead Entertainment Create a Distribution Pipeline During Sundance Film Festival
January 17, 2022 | thestreet.com
Acura Pharmaceuticals (ACUR) Stock Spikes on Development Deal with Bayer Healthcare
January 6, 2022 | prnewswire.com
Record Light Truck Sales Lead American Honda to Strong Finish in 2021 Despite Supply Issues
See More Headlines

ACUR Price History

ACUR Company Calendar

Last Earnings
2/28/2020
Today
6/01/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
OTCMKTS:ACUR
Previous Symbol
NASDAQ:ACUR
CUSIP
00509L70
CIK
786947
Web
www.acurapharm.com
Phone
(847) 705-7709
Fax
847-705-5399
Employees
12
Year Founded
1935

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$3.57 million
Price / Sales
0.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
66,000,000
Free Float
52,670,000
Market Cap
$3.30 million
Optionable
Not Optionable
Beta
2.30

Social Links


Key Executives

  • Robert B. Jones
    President, Chief Executive Officer & Director
  • Peter A. Clemens
    Chief Financial Officer, Secretary & Senior VP
  • Bob Seiser
    Treasurer, Vice President & Controller
  • Albert W. Brzeczko
    Vice President-Pharmaceutical Sciences

Key Competitors

View All Competitors













ACUR Stock - Frequently Asked Questions

How have ACUR shares performed in 2023?

Acura Pharmaceuticals' stock was trading at $0.05 on January 1st, 2023. Since then, ACUR stock has increased by 0.0% and is now trading at $0.05.
View the best growth stocks for 2023 here.

When is Acura Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our ACUR earnings forecast.

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share (EPS) for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.

What other stocks do shareholders of Acura Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD).

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acura Pharmaceuticals' stock price today?

One share of ACUR stock can currently be purchased for approximately $0.05.

How much money does Acura Pharmaceuticals make?

Acura Pharmaceuticals (OTCMKTS:ACUR) has a market capitalization of $3.30 million and generates $3.57 million in revenue each year.

Does Acura Pharmaceuticals have any subsidiaries?
The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..
Read More
How can I contact Acura Pharmaceuticals?

Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The official website for the company is www.acurapharm.com. The specialty pharmaceutical company can be reached via phone at (847) 705-7709, via email at investors@acurapharm.com, or via fax at 847-705-5399.

This page (OTCMKTS:ACUR) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -